Literature DB >> 3152488

The physiology and pathophysiology of eicosanoids in the skin.

T Ruzicka1.   

Abstract

Eicosanoids may play a role in the pathophysiology of common inflammatory skin diseases such as psoriasis and atopic eczema. Their involvement offers the hope for development of new antiinflammatory drugs for use in dermatopharmacology. On the other hand, new findings also suggest a tissue protective role of prostanoids in skin. In addition, physiological functions of lipoxygenase-derived eicosanoids are emerging, which may serve to maintain cutaneous integrity and restore normal skin structure after injury.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3152488

Source DB:  PubMed          Journal:  Eicosanoids        ISSN: 0934-9820


  5 in total

1.  Leukotriene A4 hydrolase in peripheral leukocytes of patients with atopic dermatitis.

Authors:  H Okano-Mitani; K Ikai; S Imamura
Journal:  Arch Dermatol Res       Date:  1996-04       Impact factor: 3.017

2.  12-Hydroxyeicosatetraenoic acid (12-HETE) is a chemotactic stimulus for epidermal cells.

Authors:  R Hein; E Gross; T Ruzicka; T Krieg
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

3.  Effects of cytotoxic prostaglandin, delta 12-PGJ2 on protein synthesis and cytoskeleton in transformed epidermal cells in culture.

Authors:  K Ikai; M Fukushima
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

4.  A double-blind, randomized, placebo-controlled trial of n-3 fatty acid based lipid infusion in acute, extended guttate psoriasis. Rapid improvement of clinical manifestations and changes in neutrophil leukotriene profile.

Authors:  F Grimminger; P Mayser; C Papavassilis; M Thomas; E Schlotzer; K U Heuer; D Führer; K D Hinsch; D Walmrath; W B Schill
Journal:  Clin Investig       Date:  1993-08

5.  Dithranol-induced down-regulation of 12(S)-hydroxyeicosatetraenoic acid [12(S)-HETE] receptors in a human epidermal cell line.

Authors:  L Kemény; E Gross; P Arenberger; T Ruzicka
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.